Product Information
IBANDRONATE SODIUM 150 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $2.8096 per EA under NDC 33342015052. Its NADAC has been published 52 times since Jul 2, 2025.
Strength
150 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342015052
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBANDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206887On Market Since
6/13/2018
Pharmacological Classes
Price Statistics
The NADAC for IBANDRONATE SODIUM 150 MG TAB has been published 52 times since Jul 2, 2025, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8096 per EA |
|---|---|
| All-time high | $3.5001 (Jul 16, 2025) |
| All-time low | $2.7879 (Apr 22, 2026) |
| 52-week high | $3.5001 |
| 52-week low | $2.7879 |
| Median price | $2.9258 |
| Average price | $3.0046 |
| Largest weekly change | -7.7% (Sep 17, 2025) |
| Weeks tracked | 52 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBANDRONATE SODIUM 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE SODIUM 150 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $2.8096 per EA (NDC 33342015052), effective Jun 24, 2026.
How has the price of IBANDRONATE SODIUM 150 MG TAB changed over time?
Over the history we have for it, the NADAC for IBANDRONATE SODIUM 150 MG TAB has declined 19.7%. It has been tracked across 52 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for IBANDRONATE SODIUM 150 MG TAB?
Since Jul 2, 2025, the NADAC for IBANDRONATE SODIUM 150 MG TAB has ranged from a low of $2.7879 (Apr 22, 2026) to a high of $3.5001 (Jul 16, 2025), with a median of $2.9258 per EA.
Are there cheaper alternatives to IBANDRONATE SODIUM 150 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as IBANDRONATE SODIUM 150 MG TAB, but none are currently priced below it.
Who manufactures IBANDRONATE SODIUM 150 MG TAB?
IBANDRONATE SODIUM 150 MG TAB (NDC 33342015052) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification